$141.17
4.67%
Nasdaq, Apr 21, 08:16 pm CET
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Natera, Inc. Stock price

$148.08
-1.17 0.78% 1M
+25.73 21.03% 6M
-10.22 6.46% YTD
+57.75 63.93% 1Y
+110.14 290.30% 3Y
+114.42 339.93% 5Y
+125.34 551.19% 10Y
Nasdaq, Closing price Thu, Apr 17 2025
-2.09 1.39%
ISIN
US6323071042
Symbol
NTRA
Sector
Industry

Key metrics

Market capitalization $20.02b
Enterprise Value $19.24b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 277.83
EV/Sales (TTM) EV/Sales 11.34
P/S ratio (TTM) P/S ratio 11.80
P/B ratio (TTM) P/B ratio 16.43
Revenue growth (TTM) Revenue growth 56.75%
Revenue (TTM) Revenue $1.70b
EBIT (operating result TTM) EBIT $-222.29m
Free Cash Flow (TTM) Free Cash Flow $69.24m
Cash position $968.28m
EPS (TTM) EPS $-1.53
P/E forward negative
P/S forward 10.42
EV/Sales forward 10.02
Short interest 4.32%
Show more

Is Natera, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Natera, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Natera, Inc. forecast:

22x Buy
96%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a Natera, Inc. forecast:

Buy
96%
Sell
4%

Financial data from Natera, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
1,697 1,697
57% 57%
100%
- Direct Costs 674 674
14% 14%
40%
1,023 1,023
108% 108%
60%
- Selling and Administrative Expenses 807 807
39% 39%
48%
- Research and Development Expense 404 404
26% 26%
24%
-188 -188
54% 54%
-11%
- Depreciation and Amortization 35 35
11% 11%
2%
EBIT (Operating Income) EBIT -222 -222
50% 50%
-13%
Net Profit -190 -190
56% 56%
-11%

In millions USD.

Don't miss a Thing! We will send you all news about Natera, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Natera, Inc. Stock News

Positive
Investors Business Daily
4 days ago
A revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Positive
The Motley Fool
14 days ago
Stanley Druckenmiller is in an elite league of investors that includes the likes of Warren Buffett. He ran his hedge fund firm, Duquesne Capital Management, for 30 years, posting eye-popping average annual returns of 30%.
Neutral
Business Wire
27 days ago
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, announced that it will share results from the DEFINE-HT study in a late-breaking oral presentation at the International Society for Heart and Lung Transplantation (ISHLT) 45th Annual Meeting on April 29, 2025. DEFINE-HT is the first prospective, multicenter study in heart transplan...
More Natera, Inc. News

Company Profile

Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT). The firm also offers Constellation, a cloud-based software product that allows laboratory customers to gain access to the algorithms and bioinformatics in order to validate and launch tests based on the technology. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.

Head office United States
CEO Stephen Chapman
Employees 4,434
Founded 2004
Website www.natera.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today